Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: A preliminary perspective

BioMetals

Volumn 27, Issue 1, 2014, Pages 25-31

  Pal, Amit ^a   Kumar, Ashok ^b   Prasad, Rajendra ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Copper dyshomeostasis; Network biology; Parkinson's disease; Wilson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; CERULOPLASMIN; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; HUMAN; METABOLISM; PARKINSON DISEASE; PREDICTIVE VALUE;

ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CERULOPLASMIN; COPPER; HUMANS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; SUPEROXIDE DISMUTASE;

EID: 84893822536     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-013-9702-7     Document Type: Review

References (37)

1. Ayton S, Lei P, Duce JA, Wong BX, Sedjahtera A, Adlard PA, Bush AI, Finkelstein DI (2012) Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol. doi: 10.1002/ana.23817
2. Ayton S, Lei P, Bush AI (2013) Metallostasis in Alzheimer's disease. Free Radic Biol Med 62:76-89. doi: 10.1016/j.freeradbiomed.2012.10.558
3. Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5(2):101-113. doi: 10.1038/nrg1272 (Pubitemid 38160277)
4. Bush AI (2013) The metal theory of Alzheimer's disease. J Alzheimers Dis 33(Suppl 1):S277-S281. doi: 10.3233/JAD-2012-129011
5. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ, Ideker T, Bader GD (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2(10):2366-2382. doi: 10.1038/nprot.2007.324
6. Desai V, Kaler SG (2008) Role of copper in human neurological disorders. Am J Clin Nutr 88(3):855S-858S
7. European Association for Study of Liver (2012) EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 56(3):671-685. doi: 10.1016/j.jhep.2011. 11.007
8. George JL, Mok S, Moses D, Wilkins S, Bush AI, Cherny RA, Finkelstein DI (2009) Targeting the progression of Parkinson's disease. Curr Neuropharmacol 7(1):9-36. doi: 10.2174/157015909787602814
9. Gibbs ME, Hutchinson D, Hertz L (2008) Astrocytic involvement in learning and memory consolidation. Neurosci Biobehav Rev 32(5):927-944. doi: 10.1016/j.neubiorev.2008.02.001
10. Gouider-Khouja N (2009) Wilson's disease. Parkinsonism Relat Disord 15(Suppl 3):S126-S129. doi: 10.1016/s1353-8020(09)70798-9
11. Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Zeiler B, Bornemann A, Pahnke J, Becker G, Riess O, Berg D (2004) Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology 63(10):1912-1917 (Pubitemid 39532390)
12. Hochstrasser H, Tomiuk J, Walter U, Behnke S, Spiegel J, Kruger R, Becker G, Riess O, Berg D (2005) Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J 19(13):1851-1853 (Pubitemid 41598772)
13. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR, Stokes KC, Leopold M, Multhaup G, Goldstein LE, Scarpa RC, Saunders AJ, Lim J, Moir RD, Glabe C, Bowden EF, Masters CL, Fairlie DP, Tanzi RE, Bush AI (1999) Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 274(52):37111-37116 (Pubitemid 30016785)
14. Kozlowski H, Luczkowski M, Remelli M, Valensin D (2012) Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases). Coord Chem Rev 256(19-20):2129-2141. doi: 10.1016/j.ccr.2012.03.013
15. Kristinsson J, Snaedal J, Torsdottir G, Johannesson T (2012) Ceruloplasmin and iron in Alzheimer's disease and Parkinson's disease: a synopsis of recent studies. Neuropsychiatr Dis Treat 8:515-521. doi: 10.2147/NDT.S34729
16. Kucukatay V, Agar A, Gumuslu S, Yargicoglu P (2007) Effect of sulfur dioxide on active and passive avoidance in experimental diabetes mellitus: relation to oxidant stress and antioxidant enzymes. Int J Neurosci 117(8):1091-1107. doi: 10.1080/00207450600934531 (Pubitemid 47026890)
17. +-ATPase activity impairment after experimental traumatic brain injury: relationship to spatial learning deficits and oxidative stress. Behav Brain Res 193(2):306-310. doi: 10.1016/j.bbr.2008.05.013
18. Ma Q, Li Y, Du J, Liu H, Kanazawa K, Nemoto T, Nakanishi H, Zhao Y (2006) Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS. Peptides 27(4):841-849. doi: 10.1016/j.peptides.2005.09.002
19. Mariani S, Ventriglia M, Simonelli I, Donno S, Bucossi S, Vernieri F, Melgari JM, Pasqualetti P, Rossini PM, Squitti R (2013) Fe and Cu do not differ in Parkinson's disease: a replication study plus meta-analysis. Neurobiol Aging 34(2):632-633. doi: 10.1016/j.neurobiolaging.2012.05.015
20. Olivares M, Mendez MA, Astudillo PA, Pizarro F (2008) Present situation of biomarkers for copper status. Am J Clin Nutr 88(3):859S-862S. doi: 88/3/859S
21. Pal A, Badyal RK, Vasishta RK, Attri SV, Thapa BR, Prasad R (2013a) Biochemical, histological, and memory impairment effects of chronic copper toxicity: a model for non-Wilsonian brain copper toxicosis in wistar rat. Biol Trace Elem Res 153(1-3):257-268. doi: 10.1007/s12011-013-9665-0
22. Pal A, Vasishta RK, Prasad R (2013b) Hepatic and hippocampus iron status is not altered in response to increased serum ceruloplasmin and serum "free" copper in wistar rat model for non-Wilsonian brain copper toxicosis. Biol Trace Elem Res 154(3):403-411. doi: 10.1007/s12011-013-9753-1
23. Pannasch U, Rouach N (2013) Emerging role for astroglial networks in information processing: from synapse to behavior. Trends Neurosci 36(7):405-417. doi: 10.1016/j.tins.2013.04.004
24. Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Newport GD, Murdock RC, Schlager JJ, Hussain SM, Ali SF (2009) Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 187(1):15-21. doi: 10.1016/j.toxlet.2009.01.020
25. Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, Ames D, Masters CL, AIBL research group, Bush AI (2013) Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease. J Alzheimers Dis 34(1):171-182. doi: 10.3233/JAD-121474
26. Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A (2009) Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16(3):378-385. doi: 10.1038/cdd.2008.172
27. Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 74(1):270-279 (Pubitemid 30012778)
28. Squitti R (2012) Copper dysfunction in Alzheimer's disease: from meta-analysis of biochemical studies to new insight into genetics. J Trace Elem Med Biol 26(2-3):93-96. doi: 10.1016/j.jtemb.2012.04.012
29. Squitti R, Polimanti R (2012) Copper hypothesis in the missing hereditability of sporadic Alzheimer's disease: ATP7B gene as potential harbor of rare variants. J Alzheimers Dis 29(3):493-501. doi: 10.3233/JAD-2011-111991
30. Squitti R, Polimanti R (2013) Copper phenotype in Alzheimer's disease: dissecting the pathway. Am J Neurodegener Dis 2(2):46-56
31. Squitti R, Ventriglia M, Barbati G, Cassetta E, Ferreri F, Dal Forno G, Ramires S, Zappasodi F, Rossini PM (2007) 'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm 114(12):1589-1594. doi: 10.1007/s00702-007-0777-6 (Pubitemid 350212005)
32. Squitti R, Polimanti R, Siotto M, Bucossi S, Ventriglia M, Mariani S, Vernieri F, Scrascia F, Trotta L, Rossini PM (2013) ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease. Neuromolecular Med 15(3):515-522. doi: 10.1007/s12017-013-8237
33. Squitti R, Simonelli I, Ventriglia M, Siotto M, Pasqualetti P, Rembach A, Doecke J, Bush AI (2014) Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease. J Alzheimers Dis 38(4):809-822. doi: 10.3233/JAD-131247
34. Strausak D, Mercer JF, Dieter HH, Stremmel W, Multhaup G (2001) Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull 55(2):175-185. doi: S0361-9230(01)00454-3 (Pubitemid 32722157)
35. Tiffany-Castiglion E, Qian Y (2001) Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release. Neurotoxicology 22(5):577-592 (Pubitemid 33134233)
36. Tiffany-Castiglioni E, Hong S, Qian Y (2011) Copper handling by astrocytes: insights into neurodegenerative diseases. Int J Dev Neurosci 29(8):811-818. doi: 10.1016/j.ijdevneu.2011.09.004
37. White AR, Reyes R, Mercer JF, Camakaris J, Zheng H, Bush AI, Multhaup G, Beyreuther K, Masters CL, Cappai R (1999) Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842(2):439-444. doi: S0006-8993(99)01861-2 (Pubitemid 29475178)